Gomisin A is primarily studied for its potential hepatoprotective effects, making it relevant in supporting liver health. It has shown activity in protecting liver cells from damage caused by toxins and may aid in reducing liver inflammation and fibrosis. Research also indicates antioxidant and anti-inflammatory properties, which contribute to its protective role in liver diseases such as hepatitis and fatty liver disease.

In addition, Gomisin A exhibits potential anticancer activity by inducing apoptosis and inhibiting the growth of certain tumor cells, particularly in liver, breast, and colon cancer lines. It may also influence drug-metabolizing enzymes, which suggests a role in modulating the metabolism of other drugs, though this requires careful evaluation due to possible interactions.

Emerging studies suggest metabolic benefits, including effects on glucose and lipid metabolism, pointing to possible applications in managing metabolic syndrome and type 2 diabetes. Its ability to modulate signaling pathways involved in cell survival and stress response further supports its therapeutic interest in chronic diseases.